Stock GLAB GEMINA LABORATORIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Gemina Laboratories Ltd.

Equities

GLAB

CA3686501071

Market Closed - Canadian Securities Exchange
Other stock markets
 20:22:48 21/05/2024 BST 		5-day change 1st Jan Change
0.47 CAD 0.00% Intraday chart for Gemina Laboratories Ltd. -6.00% -12.96%
04-02 Gemina Laboratories Sign First Strategic License Agreement CI
03-18 Gemina Laboratories Ltd. announced that it has received CAD 0.91 million in funding CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Gemina Laboratories : Financial Statement Request Form
PU
Gemina Laboratories : Notice of Meeting and Management Information Circular
PU
Gemina Laboratories Sign First Strategic License Agreement
CI
Gemina Laboratories Ltd. announced that it has received CAD 0.91 million in funding
CI
Gemina Laboratories Ltd. announced that it expects to receive CAD 1 million in funding
CI
Gemina Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023
CI
Gemina Laboratories Ltd. Announces the Resignation of Rob Porter as Director and President
CI
READYGO DIAGNOSTICS INITIATES AN ASSAY DEVELOPMENT CONTRACT WITH GEMINA LABORATORIES FOR THE DETECTION OF DENGUE FROM SALIVA SAMPLES
AQ
Gemina Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023
CI
Gemina Laboratories : to participate in poster session at AACC scientific meeting
PU
READYGO DIAGNOSTICS AND GEMINA LABORATORIES ANNOUNCE THE FEASIBILITY OF MYCOBACTERIUM TUBERCULOSIS (MTB) DIAGNOSIS IN SALIVA
AQ
Gemina Laboratories Ltd. Laboratories and ReadyGo Diagnostics Limited Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva
CI
Gemina Laboratories Ltd. Reports Earnings Results for the Full Year Ended January 31, 2023
CI
Gemina Laboratories Ltd. Auditor Raises 'Going Concern' Doubt
CI
Gemina Laboratories Ltd. Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement
CI
READYGO DIAGNOSTICS AND GEMINA LABORATORIES ENTER AN ASSAY DEVELOPMENT AGREEMENT FOR THE RAPID DETECTION OF MYCOBACTERIUM TUBERCULOSIS (MTB)
AQ
Gemina Laboratories Ltd. announced that it has received CAD 2.604746 million in funding
CI
Gemina Laboratories Ltd. Announces Board Changes
CI
Gemina Laboratories Ltd. Announces Board Changes
CI
Gemina Laboratories Ltd. Completes Influenza A/B Diagnostic Test Prototype
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLAB Stock
  4. News Gemina Laboratories Ltd.